EIB provides €200 million to IT travel sector leader Amadeus IT Group.
This loan will be directed to R&D activities with a focus on France.
The European Investment Bank (EIB) is providing a €200 million loan to the Amadeus IT Group, the world’s leading global distribution system (GDS) and IT solutions provider for the travel industry, based in Madrid. This financing concerns R&D activities, with a focus on France (Nice Sophia Antipolis) and is aimed at the development of a wide variety of technologies and features that will be used in different software products by airlines, airports, travel agencies and railway operators. The new developments include software frameworks, cloud migration tools, and customer experience and loyalty management applications.
Amadeus, the largest R&D investor in the IT travel sector in Europe, is a leading global provider of technology for the travel industry. This operation illustrates the EIB’s ability to support a European market leader for technological expertise and innovation. The proposed EIB loan facility is also expected to facilitate the Group’s efforts to penetrate related new market areas and continue diversifying its sources of funding.
This loan further builds on the existing relationship between the EIB and Amadeus. It will be the third loan granted to Amadeus. In 2013, the company was granted financing for €150 million, which followed a €200 million loan agreed between both entities in 2012. All three agreements have aimed at supporting R&D investment and innovation in the travel sector.
The EIB Vice-President responsible for innovation, Ambroise Fayolle, said: “We are proud to support a European champion in the IT travel industry over the long run, and the deal is proof that even in the current challenging environment, the EIB is fully mobilised to deliver on our mission to continuously support investment and innovation in Europe.”
Ana de Pro, Chief Financial Officer of Amadeus, explained: “We are proud that we have received this loan and can continue our positive and fruitful relationship with the EIB. This milestone is proof of our long-standing commitment to R&D and innovation in the travel industry, which has been key to our success over the years and which we are certain will continue playing a significant role in our future development. Investment in technology and digital solutions continues to be critical to foster competitiveness and industrial development in the European Union.”
Travel powers progress. Amadeus powers travel. Amadeus’ solutions connect travellers to the journeys they want through travel agents, search engines, tour operators, airlines, airports, hotels, cars and railways.
We have developed our technology in partnership with the travel industry for over 30 years. We combine a deep understanding of how people travel with the ability to design and deliver the most complex, trusted, critical systems our customers need. We help connect over 1.6 billion people a year to local travel providers in over 190 countries.
We are one company, with 19 000 employees across 70 offices. We have a global mindset and a local presence wherever our customers need us.
Our purpose is to shape the future of travel. We are passionate in our pursuit of better technology that makes better journeys.
Amadeus is an IBEX 35 company, listed on the Spanish Stock Exchange under AMS.MC. The company is also part of the EuroStoxx50 and has been recognised by the Dow Jones Sustainability Index for the last eight years.
The EIB is set to support the development of new treatments for progressive vascular calcification, an area of significant unmet medical need where there are currently no approved treatments. To this end, the EU bank will provide a €20 million loan to Spanish biopharmaceutical company Sanifit, which is developing novel treatments in two disease indications linked to calcification.
The EIB and Italian biotech company EryDel SpA have signed a contract to provide a loan of €30 million to EryDel. This late-stage biotech company aims to develop and commercialise therapies based on its proprietary RBC technology for the treatment of rare diseases. The EU bank’s loan is backed by a guarantee from the European Fund for Strategic Investments (EFSI), the main pillar of the Investment Plan for Europe under which the EIB and the European Commission are working together as strategic partners, with the EIB’s financing operations boosting the competitiveness of the European economy.
The EIB will lend EUR 10 million to Credo Bank, the leading actor on microfinance market in Georgia, and provide more affordable loans to country`s micro, small and medium enterprises (MSME), predominantly from the agriculture sector. This is the second loan granted under the EIB`s Georgia Outreach Initiative. Launched in December 2019 the Initiative improves financial inclusion and access to finance for underserved MSMEs in Georgia by supporting smaller banks in the country to improve their service offers.